IL-4 induces M2 macrophages to produce sustained analgesia via opioids

Melih Ö Celik1, Dominika Labuz1, Jacqueline Keye2

  • 1Department of Experimental Anesthesiology and.

JCI Insight
|February 28, 2020
PubMed

Insights

Interleukin-4 (IL-4) prompts M2 macrophages to produce natural opioids, reducing nerve injury pain. This IL-4-induced analgesia involves local opioid peptides and receptors, offering a new pain management strategy.

Area of Science:

  • Neuroimmunology
  • Pain Research
  • Cytokine Signaling

Background:

  • Interleukin-4 (IL-4) is an anti-inflammatory cytokine with known neuroprotective effects following nervous system injury.
  • Its beneficial actions are attributed to suppressing inflammatory mediators, including pro-inflammatory cytokines.
  • The precise mechanisms underlying IL-4's pain-ameliorating effects require further elucidation.

Purpose of the Study:

  • To investigate the role of IL-4 in modulating macrophage phenotype and function at sites of nerve injury.
  • To determine if IL-4-induced macrophages produce endogenous opioid peptides.
  • To assess the contribution of these opioid peptides and peripheral opioid receptors to IL-4-mediated analgesia.

Main Methods:

  • Administration of IL-4 to injured nerves in a mouse model of neuropathy.
  • Flow cytometry and immunohistochemistry to characterize macrophage phenotypes (M1 vs. M2).
  • Measurement of opioid peptide synthesis (Met-enkephalin, β-endorphin, dynorphin A 1-17) in macrophages.
  • Assessment of mechanical hypersensitivity and the effect of opioid antagonists and antibodies.
  • Adoptive transfer of M2 macrophages to evaluate their role in analgesia.

Main Results:

  • IL-4 treatment shifted macrophages from M1 to M2 phenotype at injured nerves.
  • M2 macrophages synthesized and released significant amounts of opioid peptides.
  • IL-4 administration resulted in long-lasting attenuation of mechanical hypersensitivity.
  • Analgesia was reduced by opioid peptide antibodies and antagonists, confirming opioid system involvement.
  • Adoptive transfer of IL-4-induced M2 macrophages conferred analgesia to recipient mice.

Conclusions:

  • IL-4 induces M2 macrophages at injured nerves to produce opioid peptides.
  • These opioid peptides activate peripheral opioid receptors, leading to pain reduction.
  • Targeting IL-4-induced M2 macrophage opioid production presents a potential therapeutic strategy for pathological pain.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
826
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.7K
Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
32.8K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
763
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.0K